Suppr超能文献

在初次经皮冠状动脉介入治疗(PPCI)后进行一级预防植入式心脏复律除颤器(ICD)指征的7年蒂斯河畔斯托克经验以及英国国家卫生与临床优化研究所(NICE)指南变化的潜在影响。

The 7-year teesside experience of primary prevention ICD indications following primary PCI (PPCI) and the potential impact of a change in NICE guidance.

作者信息

Phan Thanh Trung, Khan Saima, Mahmood Muhammad Muzaffar, Mani Sudha, Wadehra Vineet, de Belder Mark, Thornley Andrew, James Simon, Linker Nicholas J, Turley Andrew J

机构信息

James Cook University Hospital , Middlesbrough , UK.

Darlington Memorial Hospital , County Durham , UK.

出版信息

Open Heart. 2015 Apr 24;2(1):e000153. doi: 10.1136/openhrt-2014-000153. eCollection 2015.

Abstract

INTRODUCTION

The recovery of LV function in patients with severe LV impairment in the acute phase following primary percutaneous coronary intervention (PPCI) is not well established. The indication for a primary prevention ICD post-STEMI is dependent on which screening guidance, NICE or ESC, is followed. The potential impact of the new NICE guidance is estimated.

METHODS

We performed a retrospective analysis of all patients presenting with a STEMI over a 7-year period (2005-2012) treated with PPCI to determine in-hospital mortality, LV function at index presentation, at 3 months and the predicted primary prevention ICD implantation rate using NICE (TA095) and ESC 2006 guidelines. Predicted implant rates using the new NICE guidance (TA314) and actual implantation rates were also assessed.

RESULTS

3902 patients with a mean age of 65±13 years underwent PPCI. Of those patients surviving until discharge, 332 (10%) had LVEF ≤35%. 254 of 332 patients (76%) with a severely impaired ventricle were followed up at participating centres. 210 of 254 (83%) patients had a repeat echocardiogram within 3 months post-MI; among these patients, 89 (42%) remained to have LVEF ≤35%. The number of patients fulfilling NICE and ESC criteria for primary prevention ICD implantation was 14 (16%) and 84 (94%), respectively. The actual number of patients receiving an ICD was 17 (19%). The number of patients fulfilling the new NICE (TA314) guidance was 84 (94%).

CONCLUSIONS

A small proportion of patients with STEMIs undergoing PPCI have a severely impaired LV systolic function. A large proportion of these patients will have improved LV systolic function at 3 months. There is a five-fold difference in the predicted ICD implantation rates depending on which guidance is followed-NICE versus ESC. The potential impact of the new NICE (TA314) guidance on ICD implantation will be a significant increase in ICD implantation rates.

摘要

引言

在直接经皮冠状动脉介入治疗(PPCI)后的急性期,严重左心室(LV)功能损害患者的LV功能恢复情况尚未完全明确。ST段抬高型心肌梗死(STEMI)后一级预防植入式心律转复除颤器(ICD)的指征取决于遵循的是哪项筛查指南,即英国国家卫生与临床优化研究所(NICE)指南还是欧洲心脏病学会(ESC)指南。对新的NICE指南的潜在影响进行了评估。

方法

我们对在7年期间(2005 - 2012年)接受PPCI治疗的所有STEMI患者进行了回顾性分析,以确定住院死亡率、初次就诊时、3个月时的LV功能,以及使用NICE(TA095)和ESC 2006指南预测的一级预防ICD植入率。还评估了使用新的NICE指南(TA314)预测的植入率和实际植入率。

结果

3902例平均年龄为65±13岁的患者接受了PPCI。在存活至出院的患者中,332例(10%)左心室射血分数(LVEF)≤35%。332例心室严重受损的患者中有254例(76%)在参与研究的中心接受了随访。254例患者中有210例(83%)在心肌梗死(MI)后3个月内进行了重复超声心动图检查;在这些患者中,89例(42%)LVEF仍≤35%。符合NICE和ESC一级预防ICD植入标准的患者数量分别为14例(16%)和84例(94%)。实际接受ICD治疗的患者数量为17例(19%)。符合新的NICE(TA314)指南的患者数量为84例(94%)。

结论

接受PPCI的STEMI患者中,一小部分患者的LV收缩功能严重受损。这些患者中的很大一部分在3个月时LV收缩功能会有所改善。根据遵循的指南不同,即NICE与ESC,预测的ICD植入率相差五倍。新的NICE(TA314)指南对ICD植入的潜在影响将是ICD植入率显著增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5300/4410140/16789752a3c6/openhrt2014000153f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验